Clinical Trial Update: JMT106 Injection in the Treatment of Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating JMT106 injection for advanced solid tumors, including lung squamous cell carcinoma and hepatocellular carcinoma, is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Lung Squamous Cell Carcinoma

Drugs mentioned

• JMT106 Injection (JMT106)

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Advanced Solid Tumor, Lung Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING